Algo version: 0.98b
PTGX is listed at the NASDAQ Exchange
PTGX [PTGX]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is PTGX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Protagonist Therapeutics 10 years ago, but if you had invested on Thursday 11th of August 2016 when the price was $11.70, you would have made a profit of $28.95 per share or 247.44%

Yes, the average daily trading liquidity for Protagonist Therapeutics is $32.32 million. You should therefore be able to get in and out of your positions relatively fast.

Protagonist Therapeutics has no real debt, which is good in periods of high inflation. Protagonist Therapeutics has a very good net profit margin of 52.76% and should have very high tolerances against inflation.

We have calculated the inflation risk for Protagonist Therapeutics to be low [0.3 out of 1]